Hints and tips:
Related Special Reports
...according to the Food and Drug Administration....
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...Novo Nordisk’s Wegovy medication, which this month received US Food and Drug Administration approval to help reduce heart attack and stroke risk in patients with a history of cardiovascular problems, can...
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...Eli Lilly said that it plans to submit the results to the US Food and Drug Administration and other medicine regulators worldwide to seek approval for tirzepatide as a sleep apnoea treatment beginning this...
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...The US Food and Drug Administration says there is a shortage of Novo Nordisk’s and Eli Lilly’s diabetes drugs, while Belgium has banned the off-label use of Novo Nordisk’s diabetes drug for obesity treatments...
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...The US Food and Drug Administration on Friday approved the world’s first ever two gene therapies to treat patients with sickle cell disease....
...In just the past few years, oil and food price surges have led to exchange rate crises in Lebanon, Laos, Sri Lanka, and Pakistan....
...Cultivated meat businesses argued they undergo close scrutiny by the US Food and Drug Administration and the US Department of Agriculture before products can be eaten....
...The rush to secure manufacturing capacity comes as Wegovy and Mounjaro, which is also commonly prescribed off-label for weight loss, are in short supply, according to the US Food and Drug Administration....
...Soleno Therapeutics, a rival biotech which is expected to file for US Food and Drug Administration approval for another treatment for Prader-Willi syndrome later this year, is currently valued at nearly...
...The Food and Drug Administration on Wednesday approved Zepbound for obese and overweight adults. About 70 per cent of adults in the US are obese or overweight, the FDA said....
...and Drug Administration....
...The US Food and Drug Administration and the UK’s Medicines and Healthcare products Regulatory Agency said patients in clinical trials of Lilly’s tirzepatide had seen “significant” weight loss compared with...
...On Tuesday, the US Food and Drug Administration issued a “device safety communication” about DreamStation 2. Philips launched this gadget three years ago to replace the discredited predecessor....
...Brian Lian, Viking’s chief executive, said the company would meet regulators at the US Food and Drug Administration to assess next steps by the middle of the year....
...The US Food and Drug Administration gave approval for the trials in May....
...Zepbound generated $175.8mn in worldwide sales in the fourth quarter, after only being approved for use by the US Food and Drug Administration in November....
...The so-called consent degree, the terms of which were agreed with the US Department of Justice on behalf of the US Food and Drug Administration, is subject to approval from the relevant US court, the company...
...The abortion pill case heard on Tuesday by the Supreme Court stems from a legal challenge filed by a group of anti-abortion advocates alleging the US Food and Drug Administration did not properly approve...
...But within a year of the US Food and Drug Administration’s 2021 approval of the weight-loss drugs known as GLP-1 agonists, the threat of them breaking WW’s business model became clear....
...The chief attraction is Karuna’s new schizophrenia treatment KarXT, which it has submitted to the US Food and Drug Administration with an anticipated decision to be made by next September....
...The results were published when Eli Lilly received US Food and Drug Administration approval for its obesity treatment Zepbound, which will compete with Wegovy, and AstraZeneca entered the race for a weight-loss...
International Edition